LAB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LAB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Standard BioTools's Average Total Inventories for the three months ended in Dec. 2023 was $21.2 Mil. Standard BioTools's Cost of Goods Sold for the three months ended in Dec. 2023 was $14.8 Mil. Hence, Standard BioTools's Days Inventory for the three months ended in Dec. 2023 was 130.62.
The historical rank and industry rank for Standard BioTools's Days Inventory or its related term are showing as below:
During the past 13 years, Standard BioTools's highest Days Inventory was 150.88. The lowest was 92.65. And the median was 123.78.
Standard BioTools's Days Inventory increased from Dec. 2022 (124.95) to Dec. 2023 (130.62). It might indicate that Standard BioTools's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Standard BioTools's Inventory Turnover for the three months ended in Dec. 2023 was 0.70.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Standard BioTools's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.75.
The historical data trend for Standard BioTools's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard BioTools Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 92.65 | 111.77 | 120.80 | 126.76 | 137.16 |
Standard BioTools Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 124.95 | 154.43 | 144.66 | 141.27 | 130.62 |
For the Diagnostics & Research subindustry, Standard BioTools's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Standard BioTools's Days Inventory distribution charts can be found below:
* The bar in red indicates where Standard BioTools's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Standard BioTools's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (21.473 | + | 20.533) | / | 2 ) | / | 55.89 | * | 365 |
= | 21.003 | / | 55.89 | * | 365 | ||||
= | 137.16 |
Standard BioTools's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (21.927 | + | 20.533) | / | 2 ) | / | 14.831 | * | 365 / 4 |
= | 21.23 | / | 14.831 | * | 365 / 4 | ||||
= | 130.62 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard BioTools (NAS:LAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Standard BioTools's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 14.831 | / | 21.23 | |
= | 0.70 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Standard BioTools's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 21.23 | / | 28.188 | |
= | 0.75 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Standard BioTools's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Martin D Madaus | director | 290 CONCORD ROAD, BILLERICA MA 01821 |
Jeffrey G. Black | officer: SVP & Chief Financial Officer | 4955 DIRECTORS PLACE, SAN DIEGO CA 92121 |
Eli Casdin | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019 |
Casdin Partners Master Fund, L.p. | director, 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Casdin Partners Fo1-msv, Lp | director | C/O CASDIN PARTNERS GP, LLC, 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Casdin Private Growth Equity Fund Ii Gp, Llc | director | 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Casdin Partners Gp, Llc | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019 |
Casdin Capital, Llc | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Casdin Private Growth Equity Fund Ii, L.p. | director | 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Fenel M Eloi | director | C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452 |
Caligan Partners Lp | 10 percent owner | 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022 |
Frank Witney | director | 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451 |
Jeremy Steven Davis | officer: SVP Chief Commercial Officer | C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080 |
Hanjoon Alex Kim | officer: Chief Operating Officer | C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080 |
Michael Egholm | director, officer: President & CEO | 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110 |
From GuruFocus
By Marketwired • 08-08-2023
By PRNewswire • 01-05-2024
By Stock market mentor Stock market mentor • 01-31-2023
By sperokesalga sperokesalga • 03-22-2023
By Marketwired • 10-04-2023
By GuruFocus Research • 07-10-2023
By PRNewswire • 10-05-2023
By PRNewswire • 10-04-2023
By sperokesalga sperokesalga • 06-14-2023
By sperokesalga sperokesalga • 05-15-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.